Newsletter

298380 - ABL Bio Inc.

298380 Summary
Biopharma
Stock Price & Overview
₩71,400 +3,800 (+5.62%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩71,400  ≈ US$51  ·  Market cap ₩4.0tn (≈ $2.9bn)
Home › 298380 › Filings

5% Ownership Report — Large Holdings

DART
ABL Bio Inc.
Filed Jul 6, 2026 KST · Ownership · receipt 20260706000462

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 주식등의대량보유상황보고서(일반)

298380

Price
₩71,400
Change
+5.62%
Market cap
₩4.0tn
Prev. close
₩67,600
298380 SummaryCompare to Peers

More 298380 filings

5% Ownership Report — Large Holdings

09/04/26

Grant of stock options

08/31/26

Grant of stock options

08/26/26

Half-Year Report

08/11/26

5% Ownership Report — Large Holdings

08/04/26

Material matter affecting investment judgment (clinical trial plan amendment approved)

07/28/26